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Highlights 
1. Spatially controlled neuronal labeling is performed with a hollow silicon microelectrode 
2. Combination of iontophoretic injection with electrophysiology using a single micromachined device is 
demonstrated in acute animal experiment 
3. Mapping the projectome of locally labeled neuronal population is demonstrated as possible 
application of microiontophoresis function of a silicon neural probe. 
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Abstract 
This paper presents the results of in vivo local release of a neuronal tracer, biotinylated dextran 
amine (BDA) in the rat somatosensory cortex using monolithically integrated microfluidic 
channel of a silicon neural microelectrode. The tracer injection is controlled by iontophoresis 
using Pt electrodes in the vicinity of the outlet of the microfluidic channel. Using 3-5 µA, 5-7 s 
on/off cycle and 15-20 min total injection time the localized injection resulted in clear 
anterograde and retrograde BDA labeling both within the cortex and in subcortical structures. 
Anterograde and retrograde labeling revealed the fine details of neuronal processes including 
dendritic spines and axon terminal-like endings. Injection sites appeared clear lacking any 
strong diffuse background labeling. Electrophysiological recording performed with the same 
microdevice immediately after the iontophoresis indicated normal cortical functioning. The 
results prove that the combination of in vivo multichannel neural recording and controlled 
tracer injection using a single implanted microdevice is feasible, and therefore it can be a 
powerful tool for studying the connectome of the brain. 
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1. Introduction 
Thorough investigation of the brain’s wiring diagram is essential for understanding 
neural information processing at both local and global scales [1]. Exploring the structure and 
function of the brain’s connectome is in fact one of the major scope of recent neuroscience 
research. However, new methods and technologies need to be developed to bridge brain 
structure and function [2]. Complementing neuronal recording with pathway tracing is still an 
indispensable tool to achieve such goals specifically at the microcircuit (single neurons) and 
mesoscale (neuronal populations) levels of the neural network. However, electrophysiology and 
neuronal tract tracing are usually applied separately even if combined in the same experiment. 
Typically if recording of neural activity is also needed, an additional electrode is positioned into 
the investigated brain area close to the micropipette or glass capillary used for neuronal 
labelling [3]. Similarly, the sequential application of electrode recording and tracer injection 
within the same experiment has several shortcomings including precision issues (targeting the 
same tissue volume), increased tissue damage by multiple penetrations, long preparation of 
electrode configurations. There are several drawbacks of such an approach including the 
precise alignment of the different electrodes/syringes, crowded instrumentation and the 
invasive manner of the surgery. Therefore a device integrating both microelectric recording and 
tract tracing capabilities is highly demanded to enhance efficiency and precision of such a 
multidisciplinary approach. Also, using integrated devices simplifies the experimental 
procedures and would perhaps increase the popularity of experiments combining physiological 
and anatomical approaches. Such progress could ultimately provide significant contribution in 
understanding the connectome [4].  
 
In vivo intra- and juxtacellular recordings are usually made by electrodes filled with 
substances as e.g. biocytin, allowing the subsequent anatomical reconstruction of the neurons. 
These are important tools in exploring the neuronal microcircuitry. However, recent 
development in the field of multielectrode recording (MUR) provides new opportunities in 
examining mesoscale, population level functional and structural (spatial patterns) phenomena. 
Also, understanding the neural basis of MUR related phenomena requires knowledge about the 
underlying neuronal connectivity. Anterograde and retrograde tracing techniques are 
fundamental means of connectional neuroanatomy [5]. There are numerous substances used 
for tracing with varying chemical properties (6]. Biotinylated dextran amine (BDA) is one of the 
most popular tracers because of its sensitivity and the ease of use for different purposes 
including fluorescence and electron microscopy. BDA is widely used for labeling the origin as 
well as the termination of neural connections [4]. High molecular weight BDA (<10 kDa) yields 
higher anterograde sensitivity and provides detailed labeling of axons and terminals (target 
regions), while low molecular weight BDA (>3 kDa) yields higher sensitivity and provides 
detailed retrograde labeling of neuronal cell bodies (origin of pathways) [4]. However, it should 
be noted that in some amount BDAs of different molecular weights are transported in both 
directions and that the preference of direction can be controlled for some extent with the 
experimental procedures applied (method of injection, combined neurochemical lesion with 
Buriedfluidicchannels 
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NMDA, survival time etc.)[7]. 
BDA has been used to trace connections both within the cerebral cortex and between 
cortical and subcortical structures of different species. BDA labelling revealed projections from 
numerous regions in the CNS, e.g. from the cortex to the substantia nigra [8], from the 
brainstem [9], medulla [10], thalamus [7] etc. The two point source diffusion based real time 
techniques for drug delivery are iontophoresis and pressure ejection, both from a micropipette 
[11].  BDA can be applied both by pressure and iontophoresis. Iontophoresis is a fundamental 
technique to eject charged molecules including neuronal tracers in the brain tissue through 
establishing voltage gradient between the tracer solution suspended in a micropipette and the 
extracellular space. The advantage of iontophoresis over pressure injection is that ions and not 
the solution can be released in a modest amount by controlling the iontophoretic current [11]. 
The polarity of the applied current depends on the charge of the substance to be injected by 
iontophoresis. If there are no further charged molecules in the solution, then the amount of 
tracer deposited in the tissue is proportional to the total charge delivered by the current 
source. This implies that the electric current and injection time are the relevant parameters to 
be precisely controlled in an experiment. Mostly, pulsed direct current is used to prevent 
impedance build-up in micropipettes. One of the electrodes is a fine gauge wire which is 
inserted in the micropipette shaft. For this purpose, gold wire, silver wire, chloridized silver wire 
or stainless steel wire have been used. The other (reference) electrode is usually connected to 
some arbitrary site of the animal body, mostly outside of the brain tissue, providing a practically 
homogenous voltage gradient throughout the corpus of the animal. 
In recent years, neural microelectrodes of several functionality have been developed 
and demonstrated [12-14]. For convection enhanced drug delivery purposes, a variety of 
microdevices has been successfully tested in vivo [15-19]. In our work, we propose an in vivo 
method of using  neural microelectrode with monolithically integrated microfluidic channel to 
control tracer delivery in the close vicinity of the recording sites by iontophoresis. Additionally, 
we also prove that recording functionality is still facilitates the monitoring of local field 
potentials, single- and multiple unit activity. Detailed description of the device fabrication and 
application for convection enhanced delivery of drugs through the blood brain barrier can be 
found in our previous work [15]. 
 
2. Experimental methods 
2.1 Design & fabrication of the microfluidic channel and the microelectrodes 
The fabrication of the microelectrode is based on standard silicon MEMS process described in 
this section. The fabrication process can be found in details in [15, 20]. First, the buried 
microchannel is fabricated then the functional layers and the probe shaft were micromachined. 
The initial substrate is a 380 µm thick (100) single-crystalline silicon wafer. Thermally grown dry 
silicon-dioxide and standard Microchem 1818 photoresist were used as a masking material for 
Si etching. Silicon dioxide was patterned in C4F8 + O2 plasma using reactive ion etching. Deep 
trench etching (Bosch process) in silicon was carried out in an Oxford Plasmalab System 100 
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chamber at room temperature. After removing the photoresist, an additional 100 nm thick SiO2 
was thermally grown on the substrate and on the trench walls. Electron beam evaporation of a 
100 nm thick Al layer follows the oxidation, which acted as a protective coating during selective 
SiO2 removal from the bottom of the trench. In order to remove the SiO2 protective layer from 
the bottom of the trench, an anisotropic etch recipe using CHF3 + Ar plasma chemistry is 
utilized. The formation of microchannels (isotropic Si etch) was carried out in SF6 plasma. In 
order to remove the sidewall protection, buffered HF was used for wet chemical etching of 
both Al and SiO2 protection layers. After dehydration of the wafers at 300°C, an LPCVD process 
is applied for filling the microchannels and completely sealing the trenches by 1500 nm poly-Si 
deposition at 630°C. The formation of the buried microchannel is explained in more detail in 
[21]. Silicon wafers containing the buried microchannels were oxidized in wet atmosphere at 
1100 °C in order to grow a 50nm thick thermal SiO2 layer on the substrate surface. To further 
isolate the recording sites from the bulk Si, a  300nm thick low-stress silicon nitride (SiNx) film 
was then deposited on top of the SiO2 by LPCVD at 830 °C. A sacrificial Al layer was used to 
define the pattern of the TiOx/Pt recording sites and conductor paths via a standard lift-off 
process. First, the 300nm thick sacrificial Al layer was deposited by electron beam evaporation. 
This was followed by the first photolithography and etching steps defining the inverse pattern 
of the conductor path. The conductor layer consisted of a 15 nm thick adhesion layer of TiOx 
formed by reactive sputtering of Ti in an Ar/O2 atmosphere. In the same vacuum cycle, 270 nm 
thick Pt was sputtered on top of TiOx. The photoresist together with the overlying TiOx/Pt layer 
was removed using acetone. The Al layer was etched away as before, to complete with the lift-
off process. In the next step the upper passivation stack is formed, 300 nm thick SiO2 and SiNx 
layers were deposited using LPCVD at 430 °C and 830°C, respectively. Contact and bonding sites 
were defined by additional photolithography step followed by selective SiO2 and SiNx wet 
etching process in NH4F buffered HF and phosphorous acid until the total removal of the oxide 
and nitride layers. The probe shaft and inlet reservoirs were micromachined by dry etching 
using Bosch recipe in an Oxford Plasmasab System 100 DRIE chamber. Masking layer was 
standard photoresist on the front side, while the etch stop layers were electron beam 
evaporated Al film and subsequently spin-coated photoresist. The fabrication process can be 
found in more details in [15, 20]. 
 
The monolithically integrated microfluidic channel is 15 mm long, and 314 μm2 in cross-section. 
The fluidic outlets are on the side of the probe as presented on Fig. 1.a. The counter Pt 
electrode is 900 μm2 and the distance between the fluidic outlet and the Pt counter electrode is 
125 μm. Schematic layout of the probe tip is shown in Fig 1.b. The fluidic interfacing to the 
probe is described in our previous work in details [15].  
 
2.2 Surgery 
Animal care and experiments were performed in compliance with Animal Care Regulations of 
the Institute for Psychology of the Hungarian Academy of Sciences and order 243/1988 of the 
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Hungarian Government, which is an adaptation of directive 86/609/EGK of the European 
Committee Council. The animals were initially anesthetized via intraperitoneal injection of a 
mixture of 37.5 mg/ml ketamine and 5 mg/ml xylazine at 0.3 ml/100 g body weight injection 
volume. The sleeping state was maintained by intramuscular updates of the same solution. A 
drop of paraffin oil was applied in each eye of a rat in order to prevent them from drying. The 
anesthetized animal was placed into a stereotactic frame (David Kopf Instruments, Tujunga, CA, 
USA), head-restrained. The scalp and other soft tissues, including the periosteum covering the 
skull were removed with a scalpel. Craniotomy window was opened above the parietal lobe. 
The dura mater was incised and removed with a sharp needle. Also, the arachnoid membrane 
and the pia mater were gently poked with a fine needle tip.  
 
2.3 In vivo extracellular recording 
Electrophysiological recording was performed following the iontophoretic injections. At the 
same location, the probe was utilized for multichannel extracellular recording, using a two-
stage amplifier and a data acquisition system with a gain of 1000, 20 kHz sampling rate and 16 
bit resolution (LabView, National Instruments Corp., Austin, TX, USA) [22]. Edit 4.5 software of 
Neuroscan (Charlotte, NC, USA) was used for off-line signal visualization, filtering and analysis. 
The Klusters free software was used for clustering unit activities [23].  
 
2.4 Iontophoretic injection of BDA 
In six cases (REF, LF1, MF1, MF2, HF1, HF2) a 1:1 mixture of high and low molecular weight 
10% BDA (MW 10.000 and 3000, final cc 5 % each) (Molecular Probes, Inc. Eugene, OR, USA) 
dissolved in 0.01M phosphate buffer (pH 7.4) were used. These studies were evaluated through 
histology examinations only (see Table 1). In three further cases (REF2, PR, PRELFIZ)we used 
only the BDA 10K in 10% to test neuronal labeling followed by electrical recording through the 
same device (see Table 2.).The fluidic channel was filled with the BDA solution prior to the 
surgery. The counter Pt electrode, one among the recording sites of the multielectrode array 
(MEA) near to the opening of the channel on the shaft, was negatively biased relative to the 
channel containing the BDA, while the electrical current was measured. A positively biased 
silver electrode was placed into the fluidic channel to repel the positively charged BDA 
molecules out of the drug delivery channel. A control experiment was carried out without any 
voltage bias (injector turned off) allowing passive diffusion between the microfluidic channel 
and the extracellular space. Each injection lasted for 15 minutes and was applied by varying the 
length of the on/off cycle and the current amplitude. Injections were made at different depths 
(660-1440 µm) depending on electrode configurations (Table 3). 
 
2.5 Perfusion 
After 7 days survival period, animals were deeply anesthetized before perfusing transcardially 
with 300 ml of 0.9 % NaCl in distilled water and 500 ml fixative consisted of 4% 
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paraformaldehyde in 0.1M PB (pH 7.3). Brains were immediately removed and the region of 
interest was then cut from the cortex, flattened and postfixed for an hour in cases REF, LF1, 
MF1, MF2, HF1, HF2. Cases REF2, PR and PRELFIZ were just postfixed for an hour. 
 
2.6 Histology and microscopy 
Following dissection of the region of interest, serial sections were cut at 60 μm either in the 
horizontal (cases REF, MF1, MF2, HF1, HF2, LF1) or in the coronal plane (cases REF2, PR, 
PRELFIZ) with a vibratome. The standard ABC protocol (Elite kit, Vector Laboratories, Inc. 
Burlingame, CA, USA) was used to visualize BDA labeling with Nickel enhanced diaminobenzidin 
(Ni-DAB) (Sigma-Aldrich Kft, Budapest, Hungary) as the chromogen. In short, sections were 
rinsed in 0.1 M PB and first treated with 0.5% Triton-X 100 (Reanal Zrt., Budapest, Hungary) in 
0.1 M PB for 30 minutes. After a several washes in 0.1 M PB, intrinsic peroxidase activity was 
blocked by 1% H2O2 in PB (30 min) before the ABC step. The sections were incubated with the 
avidin/biotinylated enzyme complex (ABC, 1:200 in PB, 0.1M, pH 7.4) for 2 hours at room 
temperature and washed thoroughly. After the Ni-DAB reaction the sections were mounted on 
gelatinated slides and cover slipped with Depex (Serva Electrophoresis GmbH, Heidelberg, 
Germany).Images were collected with an Olympus research microscope equipped with a 
motorized stage (MultiControl 2000, Märzhäuser Wetzlar GmbH & Co. KG, Wetzlar, Germany) 
using the 2D Virtual Tissue module of Neurolucida® (Micro Bright Field Europe, E.K. Magdeburg, 
Germany). Except some enhancement of the contrast and brightness microscopic images were 
not edited. 
 
3. Results & Discussion 
Several successful iontophoretic injection were carried out using the microfluidic channel of 
the neural microelectrode. The implantation of the microelectrodes resulted in some tissue 
damage at the injection site, which however, apparently did not affect the injection and 
transport of BDA. In general, the applied mixture of high and low molecular weight BDA 
provided a clear labeling of neuronal cell bodies and terminals that are present in the vicinity of 
the implantation track. A representative microscopic view of a labeled neuron is shown in 
Figure 2.c. BDA labeled neurons were clearly recognizable at the site of injection, which was 
devoid of a strong diffuse background labeling. 
 
3.1 Control experiment 
To avoid any artifacts in our measurements, we carried out control in vivo experiments to 
reveal the extent of diffusion of the tracer molecules through the outlet of the fluidic channel. 
Comparison of the control experiment and the iontophoretic injection is shown in Figure 2 and 
Figure 3.  In the control case, where no current was used we did not find any labeled structures. 
In case of iontophoresis, we found anterogradely labeled axons and retrogradely labeled 
neurons. Although, in bidirectional tracing we have to consider the possibility of axonal 
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backfilling in retrogradely labeled neurons, which could be mistakenly identified as anterograde 
labeling from the injection site. However, we found dense axonal labeling distant from 
retrogradely labeled neurons, which suggest that our bidirectional tracing worked effectively. 
More detailed discussion of this methodological issue can be found in [7].   
 
3.2 Effect of the injection parameters on BDA labeling 
Detectable BDA labeling was observed only when applying current amplitude, length of the 
on/off cycle and total injection time described by previous studies using glass capillary 
electrodes [7]. Accordingly, 3-5 µA, 5-7 s on/off cycle and 15-20 min total injection time 
resulted in nice anterograde and retrograde BDA labeling both within the cortex as well as in 
subcortical structures. Interestingly, injection sites appeared very clear lacking the strong 
diffuse labeling characterizing the core region of iontophoretic injections and only a thin halo 
area was observed (Figure 2, see Table 3). No noticeable difference was observed in the BDA 
labeling when using the different types of electrode configurations. 
 
3.3 Mapping the projectome of the primary somatosensory cortical trunk region by BDA  
Figure 4 shows examples of anterograde and retrograde BDA labeling in distant cortical and 
subcortical areas including the ipsilateral cortico-cortical, callosal and thalamic connections. In 
another case in Figure 5, we show the laminar columnar organization of long distance lateral 
cortical connections. In all cases both anterograde and retrograde labeling revealed the fine 
details of neuronal processes including dendritic spines and axon terminal-like endings (Figs. 
1C-F, 2C,D). 
 
3.4 Recording of neural activity 
The probes were suitable for the detection of neurophysiological signals. Figure 6 shows 
samples of recordings, obtained after iontophoretic tracer release. The probe was slowly 
extracted from the tissue with 800 µm steps. After the second step, its proximal site reached 
the brain surface. High quality local field potential, single and multiple unit activities could be 
measured. Figure 7 A and B shows examples for single units (spikes), detected at the place of 
the tracer release and 800 µm above it, respectively. 
 
3.5 Perspective of applications 
In vivo iontophoresis in the central nervous system is mostly applied to deliver dyes and 
pathway tracers for subsequent histological studies [4, 7, 23] or to investigate the effect of 
drugs on neuronal activity [24-26]. These studies relies on the application of pulled glass 
micropipettes [24-25] or multi-barreled carbon fiber electrodes [27-28]. The combined use of 
iontophoresis and single cell electrophysiology is apparently necessary in these 
neuropharmacological studies, however, potential measurements are only based on one 
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recording site only. Our proposed device facilitates the parallel use of local iontophoresis and 
multi-electrode recording offering the observation of multiple neurons or neuronal populations 
along the probe track with limited tissue damage. Besides pathway tracing, we envision to 
exploit such advantage in fundamental behavioural animal studies in the future as well.  
 
4. Conclusion 
In this paper, the successful application of a monolithically integrated microfluidic channel in a 
neural microelectrode for local iontophoretic drug delivery and neuronal labeling is 
demonstrated in vivo. The localized injection using 3-5 µA, 5-7 s on/off cycle and 15-20 min 
total injection time resulted in clear anterograde and retrograde BDA labeling both within the 
cortex as well as in subcortical structures providing the projectome of the primary 
somatosensory cortical trunk area. In all cases, both anterograde and retrograde labeling 
revealed the fine details of neuronal processes including dendritic spines and axon terminal-like 
endings. Injection sites appeared very clear lacking the strong diffuse labeling characterizing the 
core region of iontophoretic injections and only a thin halo area was observed. No BDA labeling 
was found in control experiments, where the iontophoresis device was not turned on. 
Combined tracer injection and electrophysiology is presented in anaesthized animals using the 
very same microprobe. Tracer injection did not result in abnormal cortical functioning 
examined by electrophysiological recordings. Since the proposed device is feasible to serve 
combined labeling and electrophysiology studies with precisely (micron resolution) defined 
fluidic outlet and recording site relative positioning, we envision further applications like neural 
microcircuit and projectome mapping in animal studies. 
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Figure Captions 
Figure 1.a. SEM image of a multichannel silicon neural electrode with 12 Pt contact sites on the 
top surface and two buried microfluidic channels. The outlets of the channels are on the 
sidewalls. b: Schematic layout of the probe. Light blue lines represents the centre of the buried 
microfluidic channels. Dark blue regions are the Pt recording sites and wiring. The first Pt 
electrode was used as counter electrode during iontophoretic injection of BDA. The Pt sites are 
30x30μm2. 
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Figure 2. BDA labeling of neurons after iontophoretic injection is shown on tangential sections. 
Greyscale images taken with a light microscope. Stars indicate the electrode track. a, In case of 
MF1, BDA injection resulted in the retrograde labeling of neuronal perikarya (black arrows) in 
the vicinity of the injection site. Arrow head groups show the halo region around the injection 
site. b. No BDA labeled neurons were found in the control (case REF is shown). Note tissue 
damage at the electrode track. Scale bar: 250 µm. c. Close microscopic view of a labeled 
pyramid cell. Scale bar is 15 µm. 
  19 
 
  
  20 
Figure 3. Lack of BDA labeling in the control experiment (case REF2). A) Coronal section through 
the electrode track. Black arrow shows the injection site. orientation: D-dorsal, L-lateral. Scale 
bar represents 1 mm. B) Neither anterograde nor retrograde BDA labeling appeared at the 
injection site. Scale bar represents 100 µm. 
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Figure 4. Retrograde and anterograde BDA labeling in the cerebral cortex and the thalamus. A) 
Coronal section of the brain through the injection site (B) in case PRELFIZ. B-F) indicate the sites 
where images enlarged on the corresponding panels B-F, were taken from. Orientation: D-
dorsal, L-lateral. Scale bar represents 1 mm. B) Injection site. Black points represent the cell 
bodies of the BDA labeled neurons. Note the bilaminar accumulation with one group of labeled 
somata near the cortical surface (top of the image) and another in the middle layers shown in 
the center of the image. Note also the apical denrites represented by the numerous parallel, 
thin processes originating from the BDA labeled neurons of the middle layers and running 
upward. Scale bar represents 100 µm. C) Labeled neurons (black arrows) and axons (white 
arrows) in the cortex. Contrast inverted to enhance visibility. Scale bar represents 100 µm. D) 
BDA labeled callosal neurons (black arrows) on the cortical hemisphere contralateral to the 
injection site. Scale bar represents 100 µm. E) BDA labeled axons (white arrows) in the 
thalamus. Inverted image. Scale bar represents 50 µm. F) Retrogradely labeled neurons (black 
arrow) in the thalamus. Scale bar represents 50 µm. 
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Figure 5. Columnar appearance of the BDA labeled cortico-cortical connections in case PR. A) 
Coronal section through the injection site (black arrow). Note BDA labeling almost along the full 
depth of the cortex. Orientation: D-dorsal, L-lateral. Scale bar: 1 mm. B) BDA labeled neuronal 
cell bodies (black dots) are present all along the electrode track and accumulate in the deep 
layers. Note the lack of a dense tracer deposit and that the labeled neurons are clearly 
distinguishable. Inset: enlarged image of the area in the rectangle showing a BDA labeled 
dendritic process decorated by small thorny appendages representing spines. Scale bar 
represents 100 µm. Scale bar on inset represents 50 µm. C-D Spatial distribution of BDA labeled 
cortical connections. C) One mm anterior to the injection site retrogradely labeled neurons 
were clustered in two groups within the supra, (upper) and infragranular (lower) cortical layers 
(black arrows). Scale bar represents 100 µm. D)Approximately 1 mm caudal to the injection site 
retrograde labeling appeared only in the supragranular layers (black arrow). Scale bar 
represents 100 µm. 
  24 
 
  25 
Figure 6. Samples of neuronal activity during slow wave sleep, recorded with a linear MEA after 
iontophoresis. The bottom signals were obtained at the location of the tracer injection. The 
probe was extracted from the brain tissue with 800 µm steps. 
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Figure 7. Detected unit activities at the location of iontophoresis (A) and 800 µm above (B). 
Clusters separated with two dimensional principal component analyses are shown on the left. 
Piled SU waveforms and average SU waveforms of unit activities in different clusters are shown 
on the right. Perpendicular scale bars are 20 µV. 
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Tables 
Table 1. Parameters of the applied iontophoretic injections per surgery. 
Cases 
Measured current 
(µA) 
Length of ON/OFF cycles 
(sec) 
Rat type Weight (g) 
 
Successful injection 
of BDA 
REF 0 0 Wistar♂ 5-600 No 
LF1 1-2 12-13/5 Wistar♂ 5-600 Yes 
MF1 2-4 7/7 Wistar♂ 510 Yes 
MF2 2-4 7/7 Wistar♂ 503 Yes 
HF1 7-19 1/1 Wistar♂ 600 Yes 
HF2 1-2 1/1 Wistar♂ 520 Yes 
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Table 2. Parameters of the iontophoretic injections for coronal sectioning to map the 
projectome of the primary somatosensory trunk area. The targeted depth was 1000 µm. The 
distance of the fluidic outlet and the counter electrode is 221 µm. The size of the counter Pt 
electrode is 900 µm2. High molecular weight  BDA (10.000 K) was used as a tracer. The total 
delivery time was 15 min. * refers to the depth until the signal of injected BDA is detected 
during histology. 
Cases 
Measured 
current (µA) 
Length of 
ON/OFF 
cycles (sec) 
Rat type 
Weight 
(g) 
Anesthetic 
Depth of fluidc 
outlet (µm) 
Depth of BDA  
signal (µm)* 
REF2 - - 
Wistar, 
female 
260 
0.5 ml KX (initial)  
0.3 ml KX (updates) 
690 - 
PR 4 5/5 
Wistar, 
female 
260 
0.5 ml KX (initial)  
0.3 ml KX (updates) 
935 1140 
PRELFIZ 7 5/5 
Wistar, 
female 
260 
0.5 ml KX (initial)  
0.6 ml KX (updates) 
850 1150 
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Table 3. Parameters of iontophoretic injections. The tip of the electrodes were lowered 1000 
µm below the pial surface. * refers to the depth until the signal of injected BDA is detected 
during histology.  
Cases 
Depth of the electrode track  
(µm) 
Depth of the BDA injection 
(µm)* 
Width of the halo zone  
(µm) 
REF 480 660 - 
LF1 1320 1440 120 
MF1 1000 900 135 
MF2 840 960 170 
HF1 540 900 70 
HF2 600 900 70 
 
